Fortis nursed itself back from the initial pandemic impact. Can it stay unhurt amid the second wave?

A view of Fortis Hospital during the third phase of Covid-19 vaccination, in Mulund, on April 8, 2021 in Mumbai, India.


Over the last six months, shares of the long-troubled hospital chain have gained more than those of Apollo Hospitals, the leader among listed hospitals. Is this a fleeting phenomenon or an indication of a possible turnaround?

There is something peculiar about Fortis Healthcare. The stock did not run up when Covid-19 was declared a pandemic, nor did it touch 52-week highs during the first wave or even soon after. While shares of other hospital chains such as Apollo Hospitals started to gain momentum from September 2020 onwards, Fortis notably has been a late bloomer. Over the last six months, Apollo Hospitals has moved up by 55% and Fortis Healthcare by 63%. From

  • SAVE

Sign in to read the full article

You’ve got this Prime Story as a Free Gift

Already a Member?

Special Offer

Get Flat 20% Off


Get Offer

Why ?

  • Exclusive Economic Times Stories, Editorials & Expert opinion across 20+ sectors

  • Stock analysis. Market Research. Industry Trends on 4000+ Stocks

  • Clean experience with
    Minimal Ads

  • Comment & Engage with ET Prime community

  • Exclusive invites to Virtual Events with Industry Leaders

  • A trusted team of Journalists & Analysts who can best filter signal from noise

You may also like...

Leave a Reply

Your email address will not be published. Required fields are marked *